Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 184 for “"Structure-Based Drug Design"”.

  1. Quantum mechanical methods for structure-based drug design

    … methods are becoming popular in computational drug design and development mainly because high accuracy is required to estimate (relative) binding affinities. For low- to medium-throughput in silico screening, (e.g., scoring and prioritizing a series of inhibitors sharing the same molecular …

    zurich

  2. Structure Based Drug Design of High Affinity Kras Inhibitors

    … RAS has been aggressively targeted with drug design efforts for more than 30 years an FDA approved direct inhibitor has not yet been developed. There are three isoforms of RAS in cells; HRAS, NRAS and KRAS. We focused on KRAS since it is the most frequently mutated isoform in cancer. To …

    uthsc Repository record for Structure Based Drug Design of High Affinity Kras Inhibitors (opens in a new tab)

  3. Structure-Based Drug Design of Novel Therapeutics Targeting Oncostatin M

    … these reasons, the work presented describes the structure-based drug design, synthesis, and preliminary testing of small molecule inhibitors (SMIs) of OSM to be used as a therapeutic treatment method for metastatic breast carcinomas. Based on synthetic accessibility and computational screening, …

    boise Repository record for Structure-Based Drug Design of Novel Therapeutics Targeting Oncostatin M (opens in a new tab)

  4. Structure Based Drug Design Targeting Bacterial Antibiotic Resistance and Alzheimer's Disease

    Structure based drug design is a rapidly advancing discipline that examines how protein targets structurally interact with small molecules, or known inhibitors, and then uses this information to lead inhibitor optimization efforts. In the case of novel inhibitors, protein structural information is …

    usf Repository record for Structure Based Drug Design Targeting Bacterial Antibiotic Resistance and Alzheimer's Disease (opens in a new tab)

  5. The use of structure-based drug design to optimise protein-ligand interactions

    High attrition rates in drug candidates represent a key problem facing the pharmaceutical industry. Several studies have shown that controlling the physicochemical properties of molecules can reduce the likehood of toxicity and, thus, the risk of attrition. Fragment-based drug discovery (FBDD) is a …

    strathclyde Repository record for The use of structure-based drug design to optimise protein-ligand interactions (opens in a new tab)

  6. Structure-Based Drug Design on Enzymes of the Fatty Acid Biosynthesis Pathway

    Während die Wirkung der meisten gebräuchlichen Antibiotika auf einer Beeinträchtigung wichtiger bakterieller Prozesse beruht, wirken manche Substanzen durch die Störung der Zellmembran-Struktur. Da Fettsäuren ein essentieller Bestandteil von Membran-Phospholipiden sind, stellt die bakterielle …

    wurz-thes Repository record for Structure-Based Drug Design on Enzymes of the Fatty Acid Biosynthesis Pathway (opens in a new tab)

  7. Applications of Molecular Modelling and Structure Based Drug Design in Drug Discovery

    … other diseases. STIM1 is a promising target in drug discovery due to its key role early in calcium flux. Here we review the involvement and importance of STIM1 in diseases and we discuss STIM1 as a viable target for drug discovery using computational chemistry methods to rapidly identify new …

    usf Repository record for Applications of Molecular Modelling and Structure Based Drug Design in Drug Discovery (opens in a new tab)

  8. Computational Approaches for Structure Based Drug Design and Protein Structure-Function Prediction

    … tools like docking studies in advancing structure based drug design processes. This chapter also addresses the prime concerns like scoring functions, sampling algorithms and flexible docking studies that hamper the docking successes. Information about the different kinds of flexible …

    usf Repository record for Computational Approaches for Structure Based Drug Design and Protein Structure-Function Prediction (opens in a new tab)

  9. Investigating the role of cryo-EM as a tool for structure-based drug design

    Structure based drug design (SBDD) programs have traditionally relied upon structural information derived from X-ray crystallography. However, despite the high-resolution structures, the information obtained is a static snapshot of flexible biological systems. As the proteins are not constrained by …

    whiterose Download PDF for Investigating the role of cryo-EM as a tool for structure-based drug design (opens in a new tab)

  10. Structure-based drug design on the enoyl-ACP reductases of Yersinia pestis and Burkholderia pseudomallei

    Spreading drug resistances among Gram-negative pathogens and the paucity of new agents on the antibacterial drug market against these tenacious bacteria create a pressing need for the development of new antibiotics. The bacterial fatty acid biosynthesis pathway FAS-II, especially the enoyl-ACP …

    wurz-thes Repository record for Structure-based drug design on the enoyl-ACP reductases of Yersinia pestis and Burkholderia pseudomallei (opens in a new tab)

  11. Applications of Solid State Nuclear Magnetic Resonance Spectroscopy as a Tool for Structure Based Drug Design

    The goal of this research is to establish new drug targets and inhibitors against pathogens responsible for tropical and infectious diseases. Farnesyl diphosphate synthase, which forms farnesyl diphosphate in the isoprenoid biosynthesis pathway, is an exciting new drug target because of its central …

    uiuc Repository record for Applications of Solid State Nuclear Magnetic Resonance Spectroscopy as a Tool for Structure Based Drug Design (opens in a new tab)

  12. DISCOVERY OF A POTENT AND SELECTIVE RIOK1 INHIBITOR ACTIVE IN CRC CELL LINES USING STRUCTURE-BASED DRUG DESIGN

    … selectivity from targeting three other kinases. Based on two X-ray crystal structures of afRio1-toyocamycin complex and RIOK1(143-494)-ADP-Mg2+ complex having pAsp, toyocamycin analogs with different alkyl groups on C5’ position were designed and virtually screened in the RIOK1 crystal structure. …

    maryland Repository record for DISCOVERY OF A POTENT AND SELECTIVE RIOK1 INHIBITOR ACTIVE IN CRC CELL LINES USING STRUCTURE-BASED DRUG DESIGN (opens in a new tab)

  13. !Development of small molecule therapeutics against anti-infectious and anti-cancer drug resistance via structure-based drug design

    <p>!Drug discovery typically involves structure-based drug design based on three-dimensional protein structures and hit/lead compound identification and optimization. Herein, this technique was used to overcome several obstacles associated with the developing of antibiotics, anticancer agents, and …

    duke Repository record for !Development of small molecule therapeutics against anti-infectious and anti-cancer drug resistance via structure-based drug design (opens in a new tab)

  14. Design of Novel Inhibitors for Infectious Diseases using Structure-based Drug Design: Virtual Screening, Homology Modeling and Molecular Dynamics

    … main aim of the study in this thesis was to use structure-based protocols to design new drugs for enzymes, DXS and DXR in the non mevalonate pathway. Another aim of this study was to identify the dimer interface in E.coli FabH as an allosteric binding site for designing new class of …

    usf Repository record for Design of Novel Inhibitors for Infectious Diseases using Structure-based Drug Design: Virtual Screening, Homology Modeling and Molecular Dynamics (opens in a new tab)

  15. Discovery of small molecule modulators of protein-protein interactions by FRET-based high-throughput screening and structure-based drug design

    … arthritis. In this study, we investigated the structure-function relationship of TNFR1 by engineering a TNFR1 fluorescence resonance energy transfer (FRET) biosensor to monitor the structural and conformational changes of the receptor. We have also shown using small-molecule tool compounds, …

    umn Repository record for Discovery of small molecule modulators of protein-protein interactions by FRET-based high-throughput screening and structure-based drug design (opens in a new tab)

Page 1 of 10